Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC28A1 | O00337 | 2/20 | 0.56 |
| ▸ | ADORA3 | P0DMS8 | 7/20 | 0.54 |
| ▸ | ADORA2A | P29274 | 5/20 | 0.54 |
| ▸ | GMPS | P49915 | 1/20 | 0.48 |
| ▸ | PI4KA | P42356 | 3/20 | 0.48 |
| ▸ | PI4K2B | Q8TCG2 | 3/20 | 0.48 |
| ▸ | PI4K2A | Q9BTU6 | 3/20 | 0.48 |
| ▸ | PI4KB | Q9UBF8 | 3/20 | 0.48 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.48 |
| ▸ | DPP4 | P27487 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | MAP3K7 | O43318 | 1/20 | 0.48 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.48 |
| ▸ | GAPDH | P04406 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.48 |
| ▸ | STAT6 | P42226 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | DOT1L | Q8TEK3 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3466617 | 1.00 | SLC28A1 (0.56) | SLC28A1ADORA3ADORA2AGMPSPI4KA | |
| SCHEMBL30671963 | 0.91 | SLC28A1 (0.52) | SLC28A1ADORA3ADORA2AGMPSPI4KA | |
| SCHEMBL27220667 | 0.87 | SLC28A1 (0.42) | SLC28A1ADORA3ADORA2AGMPSPI4KA | |
| SCHEMBL29406372 | 0.87 | SLC28A1 (0.42) | SLC28A1ADORA3ADORA2AGMPSPI4KA | |
| SCHEMBL30639792 | 0.85 | AHCY (0.44) | SLC28A1ADORA3ADORA2AADORA2BADORA1 | |
| SCHEMBL9956204 | 0.85 | SLC28A1 (0.57) | SLC28A1ADORA3ADORA2AGMPSPI4KA | |
| SCHEMBL6756465 | 0.85 | SLC28A1 (0.57) | SLC28A1ADORA3ADORA2AGMPSPI4KA | |
| SCHEMBL29362292 | 0.85 | SLC28A1 (0.57) | SLC28A1ADORA3ADORA2AGMPSPI4KA | |
| SCHEMBL2335292 | 0.85 | SLC28A1 (0.57) | SLC28A1ADORA3ADORA2AGMPSPI4KA | |
| SCHEMBL66047 | 0.84 | SLC28A1 (0.56) | SLC28A1ADORA3ADORA2AGMPSPI4KA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117447532-B | Purification method of 2 '-fluoro-2' -deoxyadenosine | 江苏申基生物科技有限公司 | 2026-05-12 | — | — | CN | claimed |
| CN-119351366-A | N-deoxyribotransferase mutant and application thereof in synthesis of 2 '-fluoro-2' -deoxyadenosine analogue | 上海合全药物研发有限公司 | 2025-01-24 | — | — | CN | claimed |
| CN-117568426-A | Method for synthesizing 2 '-fluoro-2' -deoxyadenosine by whole cell catalysis | 武汉糖智药业有限公司 | 2024-02-20 | — | — | CN | claimed |
| CN-117447532-A | Purification method of 2 '-fluoro-2' -deoxyadenosine | 江苏申基生物科技有限公司 | 2024-01-26 | — | — | CN | claimed |
| CN-115725676-A | Enzymatic synthesis method of modified nucleoside | 江苏海洋大学 | 2023-03-03 | — | — | CN | claimed |
| CN-111534493-B | Purine nucleoside phosphorylase mutant, gene and application | 浙江大学宁波理工学院 | 2022-03-29 | — | — | CN | claimed |
| CN-113396219-B | Purification of mRNA by tangential flow filtration | ETHRIS GMBH (DE) | 2026-05-26 | — | — | CN | disclosed |
| CN-117447532-B | Purification method of 2 '-fluoro-2' -deoxyadenosine | 江苏申基生物科技有限公司 | 2026-05-12 | — | — | CN | disclosed |
| CN-117447532-B | Purification method of 2 '-fluoro-2' -deoxyadenosine | 江苏申基生物科技有限公司 | 2026-05-12 | — | — | CN | disclosed |
| CN-117447532-B | Purification method of 2 '-fluoro-2' -deoxyadenosine | 江苏申基生物科技有限公司 | 2026-05-12 | — | — | CN | disclosed |
| CN-119410602-B | 5' -Methylthioadenosine phosphorylase mutant and application thereof | 河北工业大学 | 2025-09-26 | — | — | CN | disclosed |
| CN-120138086-A | Process for preparing nucleoside analogues | 正大天晴药业集团股份有限公司 | 2025-06-13 | — | — | CN | disclosed |
| CN-120129532-A | Stabilized lipid or lipid nanoparticle suspensions | 埃泽瑞斯公司 | 2025-06-10 | — | — | CN | disclosed |
| CN-110234656-B | Exonucleotidase inhibitors and methods of use thereof | 卡利泰拉生物科技公司 | 2023-02-28 | — | — | CN | disclosed |
| WO-2023288111-A2 | POLYNUCLEOTIDE COMPOSITIONS AND METHODS FOR GENE EXPRESSION REGULATION | APTAH BIO, INC. (US) | 2023-01-19 | — | — | WO | disclosed |
| WO-2022269346-A2 | COMPOSITIONS AND METHODS OF MODULATING XANTHINE DEHYDROGENASE | HORIZON THERAPEUTICS IRELAND DAC (IE) | 2022-12-29 | — | — | WO | disclosed |
| WO-2022226377-A1 | COMPOSITIONS AND METHODS FOR MODULATING SOS GENE EXPRESSIONS | MOLECULAR AXIOM, LLC (US) | 2022-10-27 | — | — | WO | disclosed |
| WO-2022175684-A1 | MODIFIED ADENINES | NUCLERA NUCLEICS LTD (GB) | 2022-08-25 | — | — | WO | disclosed |
| CN-111534493-B | Purine nucleoside phosphorylase mutant, gene and application | 浙江大学宁波理工学院 | 2022-03-29 | — | — | CN | disclosed |
| WO-2022061163-A1 | METHODS, SYSTEMS AND DEVICES FOR POST-FABRICATION DRUG LOADING | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2022-03-24 | — | — | WO | disclosed |